Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution
Androgen deprivation therapy is a cornerstone of treatment for advanced prostate cancer, and the development of castrate-resistant prostate cancer (CRPC) is the primary cause of prostate cancer-related mortality. While CRPC typically develops through a gain in androgen receptor (AR) signaling, a sub...
Main Authors: | Jarrell Imamura, Shinjini Ganguly, Andrew Muskara, Ross S. Liao, Jane K. Nguyen, Christopher Weight, Christopher E. Wee, Shilpa Gupta, Omar Y. Mian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1191311/full |
Similar Items
-
Role of transcription factors and chromatin modifiers in driving lineage reprogramming in treatment-induced neuroendocrine prostate cancer
by: Amritha Sreekumar, et al.
Published: (2023-01-01) -
Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response
by: Konsta Kukkonen, et al.
Published: (2021-07-01) -
Editorial: Altered epigenetic modification mediated dysregulated transcriptional networks in drug resistance
by: Bryce Brunetti, et al.
Published: (2023-04-01) -
Oncogenes, Proto-Oncogenes, and Lineage Restriction of Cancer Stem Cells
by: Geoffrey Brown
Published: (2021-09-01) -
CHD1, a multifaceted epigenetic remodeler in prostate cancer
by: Haoyan Li, et al.
Published: (2023-01-01)